ArticleNanomaterials (Basel, Switzerland)2025
Effects of Nanofibrillar Nucleating Agent and Process Conditions on the Crystallization Behavior and Mechanical Properties of Isotactic Polypropylene.
Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Recent Advances in the Fabrication of High-Performance Polypropylene Micro-Nano Composites via Supercritical Foaming.Materials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Nanofibers, as nucleating agents, can significantly alter the nucleation and growth dynamics of polymer crystallization, thereby modulating the morphology and structure of crystals to enhance mechanical performance of the materials. In this study, the effects of nanofibrillar nucleating agent 1,3:2,4-di(3,4-dimethylbenzylidene) sorbitol (DMDBS) content, melting temperature, and injection speed on the crystallization behavior and mechanical performance of isotactic polypropylene (iPP) were systematically investigated. The incorporation of DMDBS significantly increased the number of iPP nuclei, reduced crystal size and raised the onset crystallization temperature by approximately 11 °C. Concurrently, the tensile strength and elastic modulus of injection-molded iPP samples improved by 15% and 55%, respectively. However, a rise in the melting temperature led to a decrease in the crystallinity, tensile strength, elastic modulus, and impact strength of both neat iPP and iPP/DMDBS samples. With the increase in injection speed, the tensile strength and elastic modulus of iPP/DMDBS samples increased. During the crystallization process, DMDBS crystallizes prior to the iPP melt, forming the nanofibrillar network that effectively reduced the energy barrier for iPP crystal nucleation. Furthermore, under the influence of shear forces during processing, the presence of these nanofibrillar networks promoted the formation of oriented crystalline structures, which in turn contributed to the enhanced tensile strength and elastic modulus observed in iPP samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.